| Gene symbol | IL7 | Synonyms | IL-7 | Type of gene | protein-coding |
| Chromosome | 8 | Map location | 8q21.13 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | interleukin 7 | ||||
| GTO ID | GTC3716 |
| Trial ID | NCT06204991 |
| Disease | Melanoma |
| Altered gene | IL-7 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | ADP-TILIL7 |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | Phase 1 Study to Evaluate the Safety and Efficacy of TILs Transduced With IL-7 (ADP-TILIL7) in Patients With Locally Advanced or Metastatic Melanoma |
| Year | 2024 |
| Country | Denmark |
| Company sponsor | Inge Marie Svane |
| Other ID(s) | MM2319 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||||
|
|||||||||||